2022年1月31日 · Autoimmune hemolytic anemia happens when your immune system attacks your red blood cells. Symptoms may be mild or severe and can be treated using a number of different methods. While AIHA is highly treatable, it can be serious — and even fatal — if left unaddressed.

2022年8月25日 · If you have autoimmune hemolytic anemia, your body’s immune system attacks and destroys red blood cells faster than your bone marrow can make new ones. Sometimes these red blood cells live for...

2018年11月30日 · Autoimmune hemolytic anemia (AIHA) is a decompensated acquired hemolysis caused by the host’s immune system acting against its own red cell antigens. Consequent complement activation can impact the clinical picture and is …

2018年11月8日 · Autoimmune hemolytic anemia is caused by autoantibodies that react with red blood cells at temperatures ≥ 37 ° C (warm antibody hemolytic anemia) or 37 ° C (cold agglutinin disease). Hemolysis is predominantly extravascular.

Autoimmune hemolytic anemia (AIHA) is an autoimmune disorder which occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in circulation (anemia).

Autoimmune hemolytic anemia (AIHA) is a decompensated acquired hemolysis caused by the host’s immune system acting against its own red cell antigens. Consequent complement activation can impact the clinical picture and is an emerging target for therapeutic approaches.

Autoimmune hemolytic anemia is a group of disorders characterized by a malfunction of the immune system, resulting in the production of autoantibodies that attack red blood cells as if they were substances foreign to the body.

2023年8月9日 · Autoimmune hemolytic anemia is a condition that causes your body to break down red blood cells too quickly to be replaced. Symptoms include dizziness, weakness, rapid heart rate, headaches, jaundice, and an enlarged spleen or liver.

Autoimmune hemolytic anemia (AIHA) is an uncommon disorder characterized by hemolysis mediated by autoantibodies directed against self-red blood cells (RBC), with the incidence of 1–3 per 100,000/year and mortality rate of approximately 11% [1,2].

Autoimmune hemolytic anemia (AIHA) occurs when your immune system makes antibodies that attack your red blood cells. This causes a drop in the number of red blood cells, leading to hemolytic anemia. Symptoms may include unusual weakness and fatigue with tachycardia and breathing difficulties, jaundice, dark urine and/or splenomegaly.